Y-h Chen

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.

Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.

Journal: Bone marrow transplantation

Published: June 03, 2017

Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation.

Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation.

Journal: Bone marrow transplantation

Published: May 06, 2016

Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments.

Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: September 19, 2015

Detection of human cytomegalovirus (CMV) DNA in feces has limited value in predicting CMV enteritis in patients with intestinal graft-versus-host disease after allogeneic stem cell transplantation.

Detection of human cytomegalovirus (CMV) DNA in feces has limited value in predicting CMV enteritis in patients with intestinal graft-versus-host disease after allogeneic stem cell transplantation.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 20, 2015

Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome.

Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome.

Journal: Bone marrow transplantation

Published: May 16, 2014

Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances.

Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances.

Journal: Bone marrow transplantation

Published: November 13, 2013

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis.

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis.

Journal: Bone marrow transplantation

Published: October 14, 2013

Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib.

Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib.

Journal: Bone marrow transplantation

Published: September 29, 2013

Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.

Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.

Journal: Bone marrow transplantation

Published: August 04, 2013

Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.

Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.

Journal: Leukemia

Published: May 24, 2013

Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia.

Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia.

Journal: Bone marrow transplantation

Published: January 06, 2013

Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT.

Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT.

Journal: Bone marrow transplantation

Published: January 11, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026